The Longitudinal Chronic Kidney Disease Study: A Prospective Cohort Study of Predialysis Renal Failure

Seminars in Dialysis

Volumn 16, Issue 6, 2003, Pages 418-423

  Perlman, Rachel L ^a   Kiser, Margaret ^b   Finkelstein, Fredric ^c   Eisele, George ^d   Roys, Erik ^e   Liu, Lei ^e   Burrows Hudson, Sally ^f   Port, Friedrich ^g   Messana, Joseph M ^a   Bailie, George ^d   Rajagopalan, Sanjay ^e   Saran, Rajiv ^a,h  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c YALE UNIVERSITY   (United States)

^d ALBANY MEDICAL COLLEGE   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

^f AMGEN INC   (United States)

^g Univ Ren Res and Educ Assoc   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IRON;

ADULT; ANEMIA; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIALYSIS; DISEASE COURSE; DISEASE MARKER; DISEASE SEVERITY; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FAILURE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBSERVATION; OUTPATIENT DEPARTMENT; PHASE 2 CLINICAL TRIAL; PROSPECTIVE STUDY; QUALITY OF LIFE;

ANEMIA; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; RENAL DIALYSIS;

EID: 10744225407     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2003.16093.x     Document Type: Conference Paper

References (31)

1. U.S. Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2002
2. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased renal function in the adult US population: Third Health and Nutrition Examination Survey. Am J Kidney Dis 41:1-12, 2003
3. The ACE Inhibitors in Diabetic Nephropathy Trial Group: Should all patients with type I diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? Ann Intern Med 134:370-379, 2001
4. Kshirsagar AV, Joy MS, Hogan SL, Falk RJ, Colindres RE: Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic review of randomized placebo-controlled trials. Am J Kidney Dis 35:695-707, 2000
5. Jafar TH, Schmid CH, Landa M, Giatras I, Toto R, Remuzzi G, Maschio G, Brenner BM, Kamper A, Zucchelli P, Becker G, Himmelmann A, Bannister K, Landais P, Shahinfar S, de Jong PE, de Zeeuw D, Lau J, Levey AS: Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. Ann Intern Med 135:73-87, 2001
6. Pereira BJ: Optimization of pre-ESRD care: the key to improved dialysis outcomes. Kidney Int 57:351-365, 2000
7. Stack AG: Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 41:310-318, 2003
8. Kinchen KS, Sadler J, Fink N: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137:479-486, 2002
9. Avorn J, Bohn RL, Levy E, Levin R, Owen WF, Winkelmayer WC, Glynn RJ: Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med 162:2002-2006, 2002
10. National Kidney Foundation: Executive summary. In: K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. New York: National Kidney Foundation, 2002
11. European best practice guidelines in nephrology. Nephrol Dial Transplant 14(suppl 5):1-50, 1999
12. Rao M, Kausz AT, Mitchell D, Ratican SH, Lin F, Burrows-Hudson S, Port F, Pereira BJ: The study of treatment for renal insufficiency: data and evaluation (STRIDE), a national registry of chronic kidney disease. Semin Dial 15:366-369, 2002
13. Wright TJ, Kusek JW, Toto RD, Lee JY, Agodoa LY, Kirk KA, Randall OS, Glassock R: Design and baseline characteristics of participants in the African American Study of Kidney Disease and Hypertension (AASK) pilot study. Control Clin Trials 17(4 suppl):S3-S16, 1996
14. Jager KJ, Merkus MP, Boeschoten EW, Dekker FW, Stevens P, Krediet RT, NECOSAD Study Group: Dialysis in the Netherlands: the clinical condition of new patients put into a European perspective. Nephrol Dial Transplant 14:2438-2444, 1999
15. Xue JL, St. Peter WL, Ebben JP, Everson SE, Collins AJ: Anemia treatment in the pre-ESRD period and associated mortality in elderly patients. Am J Kidney Dis 40:1153-1161, 2002
16. Fink JC, Blahut SA, Reddy M, Light PD: Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis 37:348-355, 2001
17. Korevaar JC, Merkus MP, Jansen MA, Dekker FW, Boeschoten EW, Krediet RT, NECOSAD Study Group: Validation of the KDQOL-SF™: a dialysis-targeted health measure. Qual Life Res 11:437-447, 2002
18. Kusek JW, Greene P, Wang SR, Beck G, West D, Jamerson K, Agodoa LY, Faulkner M: Level B for the African American Study of Kidney Disease and Hypertension Trial Study Group. Cross-sectional study of health related quality of life in African Americans with chronic renal insufficiency: the African American Study of Kidney Disease and Hypertension trial. Am J Kidney Dis 39:513-524, 2002
19. Ware J, Snow KK, Kosinski M, Gandek B: SF-36 health survey: manual & interpretation guide. Boston: Health Institute, 1993
20. Ware J, Kosinski M, Keller SD: SF-36 physical and mental health summary scales: a user's manual. Boston: Health Institute, 1994
21. Lopes AA, Bragg-Gresham JL, Satayathum S, McCullough K, Pifer T, Goodkin DA, Mapes DL, Young EW, Wolfe RA, Held PJ, Port FK, Worldwide DOPPS Committee: Health-related quality of life and associated outcomes among hemodialysis patients of different ethnicities in the United States: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 41:605-615, 2003
22. Walters BA, Hays RD, Spritzer KL, Fridman M, Carter WB: Health-related quality of life, depressive symptoms, anemia and malnutrition at hemodialysis initiation. Am J Kidney Dis 40:1185-1194, 2002
23. Korevaar JC, Jansen MA, Merkus MP, Dekker FW, Boeschoten EW, Krediet RT: Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy. The NECOSAD Study Group. Perit Dial Int 20:69-75, 2000
24. Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, Kasiske BL, Klag MJ, Mailloux LU, Manske CL, Meyer KB, Parfrey PS, Pfeffer MA, Wenger NK, Wilson PW, Wright JT: Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to learn? Where do we go from here? Am J Kidney Dis 32:853-906, 1998
25. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5 suppl 3):S112-S119, 1998
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130:461-470, 1999
27. Patel UD, Wright G, Roys EC, Finkelstein F, Kiser M, Eisele G, Burrows-Hudson S, Port FK, Saran R: Anemia management among patients with chronic kidney disease. J Am Soc Nephrol 13:761A, 2002
28. Bailie G, Roys EC, Eisele G, Kiser M, Finkelstein F, Wolfe RA, Mason N, Port FK, Burrows-Hudson S, Saran R: Medication use in chronic kidney disease (CKD) patients: analysis of the multicenter longitudinal CKD study. Presented at the National Kidney Foundation Clinical Meetings, Am J Kidney Dis 41:A7, 2003
29. Saran R, Wolfe RA, Roys EC, Wright G, Kiser M, Eisele G, Finkelstein F, Burrows-Hudson S, Port FK: Predictors of quality of life (Qol) in chronic kidney disease (CKD): cross-sectional analysis in the multicenter longitudinal CKD study. J Am Soc Nephrol 13:520A, 2002
30. Perlman R, Roys EC, Finkelstein F, Kiser M, Eisele G, Burrows-Hudson S, Messana J, Port FK, Wolfe RA, Saran R: Quality of life (QOL) in patients with chronic kidney disease (CKD): a longitudinal study. Presented at the National Kidney Foundation Clinical Meetings, Am J Kidney Dis 41:A8, 2003
31. Feldman HI, Appel LJ, Chertow GM, Cifelli D, Cizman B, Daugirdas J, Fink JC, Franklin-Becker ED, Go AS, Hamm LL, He J, Hostetter T, Hsu CY, Jamerson K, Joffe M, Kusek JW, Landis JR, Lash JP, Miller ER, Mohler ER 3rd, Muntner P, Ojo AO, Rahman M, Townsend RR, Wright JT; Chronic Renal Insufficiency Cohort (CRIC) Study Investigators. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol 14(7 Suppl 2):S148-153, 2003